世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000040933

フランス、ドイツ、イタリア、スペイン、イギリスにおけるヨーロッパの血液バンク市場シェア(2024年)- 主要市場プレーヤーと新興市場プレーヤーの競争分析

VPGMarketResearch

2024 Europe Blood Banking Market Shares in France, Germany, Italy, Spain, UK--Competitive Analysis of Leading and Emerging Market Players

発刊日 2025/01/21

言語英語

体裁PDF

ライセンス/価格

0000040933

Local PDF
Global PDF

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。電子媒体での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

この新しいレポートは、フランス、ドイツ、イタリア、スペイン、イギリスの血液バンク市場シェアを提供します。

このレポートは、血液バンク分析装置および試薬の現在および新興のサプライヤーを分析しており、その売上高、製品ポートフォリオ、マーケティング戦略、技術的ノウハウ、研究開発の新製品、協力協定およびビジネス戦略が含まれています。このレポートで調査されている企業は次のとおりです。

  • Abbott
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biokit
  • bioMerieux
  • Bio-Rad
  • Diagast
  • DiaSorin
  • 富士レビオ(Fujirebio)
  • Grifols
  • Hologic
  • Immucor
  • LabCorp
  • Proteome Sciences
  • Quest Diagnostics
  • QuidelOrtho
  • Roche
  • Siemens Healthineers
  • Tecan
  • Thermo Fisher

レポート詳細

目次

Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- LabCorp
- Proteome Sciences
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher
- Werfen

List of Tables
All Market Segments Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Diagnostics Market Forecast
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests Major
Companies Developing or Marketing Giardia Tests Major
Companies Developing or Marketing Gonorrhea Tests Major
Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests Major
Companies Developing or Marketing Meningitis Tests Major
Companies Developing or Marketing Microsporidium Tests Major
Companies Developing or Marketing Mononucleosis Tests Major
Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests

Competitive Assessments
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- LabCorp
- Proteome Sciences
- Quest Diagnostics
- QuidelOrtho
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher
- Werfen

List of Tables
All Market Segments Infectious Disease Test Volume Forecast
All Market Segments Infectious Disease Diagnostics Market Forecast
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests Major
Companies Developing or Marketing Giardia Tests Major
Companies Developing or Marketing Gonorrhea Tests Major
Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests Major
Companies Developing or Marketing Meningitis Tests Major
Companies Developing or Marketing Microsporidium Tests Major
Companies Developing or Marketing Mononucleosis Tests Major
Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests

この商品のレポートナンバー

0000040933

最近見たレポート

気管支生検デバイス市場-規模、シェア、動向分析レポート、およびセグメント予測、2023〜2030

Bronchial Biopsy Devices Market Size, Share & Trends Analysis Report, And Segment Forecasts, 2023- 2030

2023/09/01

5,950 USD

腫瘍マーカー検査のラテンアメリカ市場(2023〜2027年)- がん診断検査および分析装置の高成長機会 - 22カ国の分析 - サプライヤーのシェアと戦略、主要腫瘍マーカーの検査量と売上セグメントの予測、最新技術と機器パイプライン、サプライヤーの新たな機会

2023-2027 Latin America Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--A 22-Country Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2023/09/25

14,500 USD

乳がん診断のアメリカ市場(2023〜2027年)- CEA、CA 15-3、CA 27.29、CA 125、エストロゲン受容体、HER2、ポリペプチド特異抗原、プロゲステロン受容体 - 国別データベースと分析 - サプライヤーのシェアと戦略、販売量と売上セグメントの予測、新興技術、最新の機器、成長の機会

2023-2027 U.S. Breast Cancer Diagnostics Market--CEA, CA 15-3, CA 27.29,CA 125, Estrogen Receptor, HER2, Polypeptide-Specific Antigen, Progesterone Receptor--Country Database and Analysis--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation, Growth Opportunities

2023/09/25

2,450 USD

腫瘍マーカー検査のドイツ市場(2023〜2027年)- がん診断検査および分析装置の高成長機会 - サプライヤーのシェアと戦略、主要腫瘍マーカーの検査量と売上セグメントの予測、最新技術と機器パイプライン、サプライヤーの新たな機会

2023-2027 Germany Tumor Markers Testing Market--High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers--Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers

2023/09/25

3,500 USD

体外診断市場(タイプ別、技術別、用途別、およびエンドユーザー別)- 世界の機会分析と業界予測(2025〜2030年)

In-Vitro Diagnostic Market by Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Others), and by End User (Stand Alone, Laboratory, Hospitals, Academics and Medical Schools, Point of Care Testing, and Other End Users) - Global Opportunity Analysis and Industry Forecast, 2025-2030

2024/12/05

3,975 USD

炎症性腸疾患治療の世界市場レポート(2025年)

Inflammatory Bowel Disease Treatment Global Market Report 2025

2025/02/04

4,490 USD

TOP